Valium

— THERAPEUTIC CATEGORIES —
  • Addiction/dependence
  • Anxiety/OCD
  • Muscle spasms
  • Seizure disorders

Valium Generic Name & Formulations

General Description

Diazepam 2mg, 5mg, 10mg; scored tabs.

Pharmacological Class

Benzodiazepine.

See Also

    How Supplied

    Tabs 2mg—100; Tabs 5mg, 10mg—100, 500; Vials (10mL)—contact supplier

    Manufacturer

    Mechanism of Action

    Diazepam is a benzodiazepine that exerts anxiolytic, sedative, muscle-relaxant, anticonvulsant and amnestic effects. Most of these effects are thought to result from a facilitation of the action of gamma aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system.

    Valium Indications

    Indications

    Acute alcohol withdrawal.

    Valium Dosage and Administration

    Adult

    Initially 10mg 3–4 times during the first 24hrs, then reduce to 5mg 3–4 times daily as needed.

    Children

    Not established.

    Valium Contraindications

    Contraindications

    Children <6months. Myasthenia gravis. Severe respiratory insufficiency. Severe hepatic insufficiency. Sleep apnea syndrome. Acute narrow-angle glaucoma. Untreated open angle glaucoma.

    Valium Boxed Warnings

    Boxed Warning

    Risks from concomitant use with opioids. Abuse, misuse, and addiction. Dependence and withdrawal reactions.

    Valium Warnings/Precautions

    Warnings/Precautions

    Increased risk of drug-related mortality from concomitant use with opioids. Monitor for CNS depressant effects. Discontinue if paradoxical reaction occurs. Respiratory insufficiency. Depression. Suicidal tendencies. Psychosis. May increase severity of seizures. Renal or hepatic impairment. Assess patient's risk for abuse, misuse, addiction prior to and during therapy. Avoid abrupt cessation. Reevaluate periodically. Monitor blood counts, liver function. Inj: not for use in shock, coma, acute alcohol intoxication, or obstetrical conditions. Drug or alcohol abusers. Elderly. Debilitated. Labor & delivery. Neonatal sedation and withdrawal syndrome; monitor neonates exposed during pregnancy or labor. Pregnancy (esp. late stage). Nursing mothers: not recommended.

    Valium Pharmacokinetics

    Absorption

    Oral diazepam absorption: >90%. Mean time to peak plasma concentration: 1–1.5 hours (range: 0.25–2.5 hours). Absorption is decreased and delayed when administered with a moderate fat meal.

    Distribution

    Plasma protein bound: 98%. Volume of distribution: 0.8–1.0 L/kg.

    Metabolism

    Hepatic (CYP3A4).

    Elimination

    Renal. Terminal half-life: up to 100 hours (N-desmethyldiazepam).

    Valium Interactions

    Interactions

    Increased sedation, respiratory depression, coma, and death with concomitant opioids; reserve use in those for whom alternative treatment options are inadequate; if needed, limit dosages/durations to minimum and monitor. Potentiates CNS depression with alcohol, other CNS depressants (eg, phenothiazines, antipsychotics, anxiolytics/sedatives, hypnotics, anticonvulsants, narcotic analgesics, anesthetics, antihistamines, barbiturates, MAOIs, other antidepressants). Potentiated by CYP3A or CYP2C19 inhibitors (eg, cimetidine, fluoxetine, fluvoxamine, ketoconazole, omeprazole). May affect or be affected by phenytoin.

    Valium Adverse Reactions

    Adverse Reactions

    Drowsiness, fatigue, muscle weakness, ataxia, CNS effects, GI disturbances, hypotension, salivation changes, neutropenia, jaundice; paradoxical excitement. Inj: apnea, cardiac arrest, venous thrombosis, phlebitis, local irritation, swelling, tonic status epilepticus (when treating petit mal), propylene glycol toxicity, withdrawal reactions.

    Valium Clinical Trials

    See Literature

    Valium Note

    Not Applicable

    Valium Patient Counseling

    See Literature

    Valium Generic Name & Formulations

    General Description

    Diazepam 2mg, 5mg, 10mg; scored tabs.

    Pharmacological Class

    Benzodiazepine.

    How Supplied

    Tabs 2mg—100; Tabs 5mg, 10mg—100, 500; Vials (10mL)—contact supplier

    Manufacturer

    Mechanism of Action

    Diazepam is a benzodiazepine that exerts anxiolytic, sedative, muscle-relaxant, anticonvulsant and amnestic effects. Most of these effects are thought to result from a facilitation of the action of gamma aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system.

    Valium Indications

    Indications

    Anxiety.

    Valium Dosage and Administration

    Adult

    2–10mg 2–4 times daily. Elderly, debilitated: initially 2–2.5mg 1–2 times daily; increase gradually.

    Children

    <6months: See Contraindications. ≥6months: initially 1–2.5mg 3–4 times daily; increase gradually.

    Valium Contraindications

    Contraindications

    Children <6months. Myasthenia gravis. Severe respiratory insufficiency. Severe hepatic insufficiency. Sleep apnea syndrome. Acute narrow-angle glaucoma. Untreated open angle glaucoma.

    Valium Boxed Warnings

    Boxed Warning

    Risks from concomitant use with opioids. Abuse, misuse, and addiction. Dependence and withdrawal reactions.

    Valium Warnings/Precautions

    Warnings/Precautions

    Increased risk of drug-related mortality from concomitant use with opioids. Monitor for CNS depressant effects. Discontinue if paradoxical reaction occurs. Respiratory insufficiency. Depression. Suicidal tendencies. Psychosis. May increase severity of seizures. Renal or hepatic impairment. Assess patient's risk for abuse, misuse, addiction prior to and during therapy. Avoid abrupt cessation. Reevaluate periodically. Monitor blood counts, liver function. Inj: not for use in shock, coma, acute alcohol intoxication, or obstetrical conditions. Drug or alcohol abusers. Elderly. Debilitated. Labor & delivery. Neonatal sedation and withdrawal syndrome; monitor neonates exposed during pregnancy or labor. Pregnancy (esp. late stage). Nursing mothers: not recommended.

    Valium Pharmacokinetics

    Absorption

    Oral diazepam absorption: >90%. Mean time to peak plasma concentration: 1–1.5 hours (range: 0.25–2.5 hours). Absorption is decreased and delayed when administered with a moderate fat meal.

    Distribution

    Plasma protein bound: 98%. Volume of distribution: 0.8–1.0 L/kg.

    Metabolism

    Hepatic (CYP3A4).

    Elimination

    Renal. Terminal half-life: up to 100 hours (N-desmethyldiazepam).

    Valium Interactions

    Interactions

    Increased sedation, respiratory depression, coma, and death with concomitant opioids; reserve use in those for whom alternative treatment options are inadequate; if needed, limit dosages/durations to minimum and monitor. Potentiates CNS depression with alcohol, other CNS depressants (eg, phenothiazines, antipsychotics, anxiolytics/sedatives, hypnotics, anticonvulsants, narcotic analgesics, anesthetics, antihistamines, barbiturates, MAOIs, other antidepressants). Potentiated by CYP3A or CYP2C19 inhibitors (eg, cimetidine, fluoxetine, fluvoxamine, ketoconazole, omeprazole). May affect or be affected by phenytoin.

    Valium Adverse Reactions

    Adverse Reactions

    Drowsiness, fatigue, muscle weakness, ataxia, CNS effects, GI disturbances, hypotension, salivation changes, neutropenia, jaundice; paradoxical excitement. Inj: apnea, cardiac arrest, venous thrombosis, phlebitis, local irritation, swelling, tonic status epilepticus (when treating petit mal), propylene glycol toxicity, withdrawal reactions.

    Valium Clinical Trials

    See Literature

    Valium Note

    Not Applicable

    Valium Patient Counseling

    See Literature

    Valium Generic Name & Formulations

    General Description

    Diazepam 2mg, 5mg, 10mg; scored tabs.

    Pharmacological Class

    Benzodiazepine.

    How Supplied

    Tabs 2mg—100; Tabs 5mg, 10mg—100, 500; Vials (10mL)—contact supplier

    Manufacturer

    Mechanism of Action

    Diazepam is a benzodiazepine that exerts anxiolytic, sedative, muscle-relaxant, anticonvulsant and amnestic effects. Most of these effects are thought to result from a facilitation of the action of gamma aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system.

    Valium Indications

    Indications

    Skeletal muscle spasm.

    Valium Dosage and Administration

    Adult

    2–10mg 3–4 times daily. Elderly, debilitated: initially 2–2.5mg 1–2 times daily; increase gradually.

    Children

    <6months: See Contraindications. ≥6months: initially 1–2.5mg 3–4 times daily; increase gradually.

    Valium Contraindications

    Contraindications

    Children <6months. Myasthenia gravis. Severe respiratory insufficiency. Severe hepatic insufficiency. Sleep apnea syndrome. Acute narrow-angle glaucoma. Untreated open angle glaucoma.

    Valium Boxed Warnings

    Boxed Warning

    Risks from concomitant use with opioids. Abuse, misuse, and addiction. Dependence and withdrawal reactions.

    Valium Warnings/Precautions

    Warnings/Precautions

    Increased risk of drug-related mortality from concomitant use with opioids. Monitor for CNS depressant effects. Discontinue if paradoxical reaction occurs. Respiratory insufficiency. Depression. Suicidal tendencies. Psychosis. May increase severity of seizures. Renal or hepatic impairment. Assess patient's risk for abuse, misuse, addiction prior to and during therapy. Avoid abrupt cessation. Reevaluate periodically. Monitor blood counts, liver function. Inj: not for use in shock, coma, acute alcohol intoxication, or obstetrical conditions. Drug or alcohol abusers. Elderly. Debilitated. Labor & delivery. Neonatal sedation and withdrawal syndrome; monitor neonates exposed during pregnancy or labor. Pregnancy (esp. late stage). Nursing mothers: not recommended.

    Valium Pharmacokinetics

    Absorption

    Oral diazepam absorption: >90%. Mean time to peak plasma concentration: 1–1.5 hours (range: 0.25–2.5 hours). Absorption is decreased and delayed when administered with a moderate fat meal.

    Distribution

    Plasma protein bound: 98%. Volume of distribution: 0.8–1.0 L/kg.

    Metabolism

    Hepatic (CYP3A4).

    Elimination

    Renal. Terminal half-life: up to 100 hours (N-desmethyldiazepam).

    Valium Interactions

    Interactions

    Increased sedation, respiratory depression, coma, and death with concomitant opioids; reserve use in those for whom alternative treatment options are inadequate; if needed, limit dosages/durations to minimum and monitor. Potentiates CNS depression with alcohol, other CNS depressants (eg, phenothiazines, antipsychotics, anxiolytics/sedatives, hypnotics, anticonvulsants, narcotic analgesics, anesthetics, antihistamines, barbiturates, MAOIs, other antidepressants). Potentiated by CYP3A or CYP2C19 inhibitors (eg, cimetidine, fluoxetine, fluvoxamine, ketoconazole, omeprazole). May affect or be affected by phenytoin.

    Valium Adverse Reactions

    Adverse Reactions

    Drowsiness, fatigue, muscle weakness, ataxia, CNS effects, GI disturbances, hypotension, salivation changes, neutropenia, jaundice; paradoxical excitement. Inj: apnea, cardiac arrest, venous thrombosis, phlebitis, local irritation, swelling, tonic status epilepticus (when treating petit mal), propylene glycol toxicity, withdrawal reactions.

    Valium Clinical Trials

    See Literature

    Valium Note

    Not Applicable

    Valium Patient Counseling

    See Literature

    Valium Generic Name & Formulations

    General Description

    Diazepam 2mg, 5mg, 10mg; scored tabs.

    Pharmacological Class

    Benzodiazepine.

    How Supplied

    Tabs 2mg—100; Tabs 5mg, 10mg—100, 500; Vials (10mL)—contact supplier

    Manufacturer

    Mechanism of Action

    Diazepam is a benzodiazepine that exerts anxiolytic, sedative, muscle-relaxant, anticonvulsant and amnestic effects. Most of these effects are thought to result from a facilitation of the action of gamma aminobutyric acid (GABA), an inhibitory neurotransmitter in the central nervous system.

    Valium Indications

    Indications

    Adjunct in convulsive disorders.

    Valium Dosage and Administration

    Adult

    2–10mg 2–4 times daily. Elderly, debilitated: initially 2–2.5mg 1–2 times daily; increase gradually.

    Children

    <6months: See Contraindications. ≥6months: initially 1–2.5mg 3–4 times daily; increase gradually.

    Valium Contraindications

    Contraindications

    Children <6months. Myasthenia gravis. Severe respiratory insufficiency. Severe hepatic insufficiency. Sleep apnea syndrome. Acute narrow-angle glaucoma. Untreated open angle glaucoma.

    Valium Boxed Warnings

    Boxed Warning

    Risks from concomitant use with opioids. Abuse, misuse, and addiction. Dependence and withdrawal reactions.

    Valium Warnings/Precautions

    Warnings/Precautions

    Increased risk of drug-related mortality from concomitant use with opioids. Monitor for CNS depressant effects. Discontinue if paradoxical reaction occurs. Respiratory insufficiency. Depression. Suicidal tendencies. Psychosis. May increase severity of seizures. Renal or hepatic impairment. Assess patient's risk for abuse, misuse, addiction prior to and during therapy. Avoid abrupt cessation. Reevaluate periodically. Monitor blood counts, liver function. Inj: not for use in shock, coma, acute alcohol intoxication, or obstetrical conditions. Drug or alcohol abusers. Elderly. Debilitated. Labor & delivery. Neonatal sedation and withdrawal syndrome; monitor neonates exposed during pregnancy or labor. Pregnancy (esp. late stage). Nursing mothers: not recommended.

    Valium Pharmacokinetics

    Absorption

    Oral diazepam absorption: >90%. Mean time to peak plasma concentration: 1–1.5 hours (range: 0.25–2.5 hours). Absorption is decreased and delayed when administered with a moderate fat meal.

    Distribution

    Plasma protein bound: 98%. Volume of distribution: 0.8–1.0 L/kg.

    Metabolism

    Hepatic (CYP3A4).

    Elimination

    Renal. Terminal half-life: up to 100 hours (N-desmethyldiazepam).

    Valium Interactions

    Interactions

    Increased sedation, respiratory depression, coma, and death with concomitant opioids; reserve use in those for whom alternative treatment options are inadequate; if needed, limit dosages/durations to minimum and monitor. Potentiates CNS depression with alcohol, other CNS depressants (eg, phenothiazines, antipsychotics, anxiolytics/sedatives, hypnotics, anticonvulsants, narcotic analgesics, anesthetics, antihistamines, barbiturates, MAOIs, other antidepressants). Potentiated by CYP3A or CYP2C19 inhibitors (eg, cimetidine, fluoxetine, fluvoxamine, ketoconazole, omeprazole). May affect or be affected by phenytoin.

    Valium Adverse Reactions

    Adverse Reactions

    Drowsiness, fatigue, muscle weakness, ataxia, CNS effects, GI disturbances, hypotension, salivation changes, neutropenia, jaundice; paradoxical excitement. Inj: apnea, cardiac arrest, venous thrombosis, phlebitis, local irritation, swelling, tonic status epilepticus (when treating petit mal), propylene glycol toxicity, withdrawal reactions.

    Valium Clinical Trials

    See Literature

    Valium Note

    Not Applicable

    Valium Patient Counseling

    See Literature